Novel tetrazolyl-1,2,3-triazole derivatives as potent antimicrobial targets: design, synthesis and molecular docking techniques

The main objective of this study is to produce novel triazoles-loaded tetrazoles, which are crucial in the development of prospective therapeutic agents in medicinal chemistry. Recent investigations have found a wide range of uses for these derivatives, and they are prospective lead molecules for the synthesis of substances with enormous therapeutic utility for various diseases, especially for bacterial therapy. New series of 1,2,3-triazole derivatives have been synthesized from methyl (2S,4S)-4-azido-1-(2,4-difluoro-3-methylbenzoyl)pyrrolidine-2-carboxylate (<b>5</b>) using a well-established click reaction that has several advantages to afford a novel heterocyclic compound based on tetrazole moieties. The structures of the new compounds were ascertained by spectral means (IR, NMR: <sup>1</sup>H and <sup>13</sup>C) and mass spectrum. All the synthesized compounds were assessed <i>in vitro</i> antimicrobial activity against Gram-+ve (<i>S. pyogenes</i>, <i>S. aureus</i> and <i>B. subtilis</i>), Gram-negative (<i>E. coli</i> and <i>P. aeruginosa</i>) bacterial and fungal strains <i>A. flavus</i> and <i>C. albicans</i>. The prepared compounds <b>7b</b> and<b>7f</b> proved to have strong impact on <i>S. aureus</i> and <i>S. pyogenes</i> strains with MICs of 2.5 µg/mL and 1.5 µg/mL respectively. Among the tested compounds, hybrids <b>7b</b>, <b>7f</b>, <b>7h</b>, and <b>7i</b> exhibited exceptional antifungal susceptibilities against <i>C. albicans</i> with zone of inhibition 25 ± 0.2, 30 ± 0.3, 30 ± 0.1, and 28 ± 0.2 mm respectively, which is stronger than fluconazole (28 ± 0.1 mm). The capacity of ligand <b>7f</b> to form a stable compound on the active site of <i>S. aureus</i> complex with DNA Gyrase (2XCT) was confirmed by docking studies using amino acids Ala233(A), Arg234(A), Gly283(A), Ser286(A), Lys52(A), His280(A), Gly51(A), His282(A) and Val246(A). Furthermore, the physicochemical and ADME (absorption, distribution, metabolism, and excretion) filtration molecular properties, estimation of toxicity, and bioactivity scores of these scaffolds were evaluated.

Authors

Institutions

Publication Details

Journal
Journal of Biomolecular Structure and Dynamics
Published
2024-11-19
DOI
https://doi.org/10.1080/07391102.2024.2425830
Citations
1
Primary Topic
Synthesis and biological activity
Type
article
Field-Weighted Citation Impact
0.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel tetrazolyl-1,2,3-triazole derivatives as potent antimicrobial targets: design, synthesis and molecular docking techniques

Sharath Babu Haridasyam, Tejeswara Rao Allaka, Sunil Kumar Nechipadappu, Kalyani Chepuri et al.
1 citations
Journal of Biomolecular Structure and Dynamics
Synthesis and biological activity
0.25
article

Novel tetrazolyl-1,2,3-triazole derivatives as potent antimicrobial targets: design, synthesis and molecular docking techniques

Sharath Babu Haridasyam, Tejeswara Rao Allaka, Sunil Kumar Nechipadappu, Kalyani Chepuri, Venkanna Gujja, Kumaraswamy Sadineni, Venkatanaryana Muvvala, Kishore Veera Venkata Nanda Pilli
article en
1 citations

Abstract

The main objective of this study is to produce novel triazoles-loaded tetrazoles, which are crucial in the development of prospective therapeutic agents in medicinal chemistry. Recent investigations have found a wide range of uses for these derivatives, and they are prospective lead molecules for the synthesis of substances with enormous therapeutic utility for various diseases, especially for bacterial therapy. New series of 1,2,3-triazole derivatives have been synthesized from methyl (2S,4S)-4-azido-1-(2,4-difluoro-3-methylbenzoyl)pyrrolidine-2-carboxylate (<b>5</b>) using a well-established click reaction that has several advantages to afford a novel heterocyclic compound based on tetrazole moieties. The structures of the new compounds were ascertained by spectral means (IR, NMR: <sup>1</sup>H and <sup>13</sup>C) and mass spectrum. All the synthesized compounds were assessed <i>in vitro</i> antimicrobial activity against Gram-+ve (<i>S. pyogenes</i>, <i>S. aureus</i> and <i>B. subtilis</i>), Gram-negative (<i>E. coli</i> and <i>P. aeruginosa</i>) bacterial and fungal strains <i>A. flavus</i> and <i>C. albicans</i>. The prepared compounds <b>7b</b> and<b>7f</b> proved to have strong impact on <i>S. aureus</i> and <i>S. pyogenes</i> strains with MICs of 2.5 µg/mL and 1.5 µg/mL respectively. Among the tested compounds, hybrids <b>7b</b>, <b>7f</b>, <b>7h</b>, and <b>7i</b> exhibited exceptional antifungal susceptibilities against <i>C. albicans</i> with zone of inhibition 25 ± 0.2, 30 ± 0.3, 30 ± 0.1, and 28 ± 0.2 mm respectively, which is stronger than fluconazole (28 ± 0.1 mm). The capacity of ligand <b>7f</b> to form a stable compound on the active site of <i>S. aureus</i> complex with DNA Gyrase (2XCT) was confirmed by docking studies using amino acids Ala233(A), Arg234(A), Gly283(A), Ser286(A), Lys52(A), His280(A), Gly51(A), His282(A) and Val246(A). Furthermore, the physicochemical and ADME (absorption, distribution, metabolism, and excretion) filtration molecular properties, estimation of toxicity, and bioactivity scores of these scaffolds were evaluated.

Journal of Biomolecular Structure and DynamicsVol. 44(3)
Jawaharlal Nehru Technological University, Hyderabad (IN), Vignan's Foundation for Science, Technology & Research (IN), Indian Institute of Chemical Technology (IN), GITAM University (IN)
Openalex Percentile: Top 46%
Synthesis and biological activity
0.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.